Back to Agenda
S10 : Impact of ICH E6 (R3) on GCP Inspection: from Global Perspectives
Session Chair(s)
Junko Sato, PHD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Kotaro Fukuda
, Pharmaceuticals and Medical Devices Agency, Japan
Mitsuaki Aoyagi
, Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Yoshiaki Ohyama
Director, Professor, Innovative Medical Reserch Center, Gunma University Hospital, Japan
Yuka Kubota
Innovative Medical Research Center, Gunma University Hospital, Japan
Have an account?